CLSA was recently featured in the San Diego Business Journal regarding the expansion of its board of directors.
Did you miss our Evening with Thought Leaders program last week? Check out this BioSpace piece for a recap of the key policy issues discussed by Jim Greenwood of BIO, Janet Trunzo of AdvaMed and Melinda Richter of Johnson & Johnson Innovation | JLABS.
CLSA’s Evening With Thought Leaders Event was recently featured in the San Diego Union-Tribune.
CLSA President & CEO Mike Guerra recently sat down with Global Business Reports to discuss CLSA’s mission, as well as the commitment of our members in helping patients, while boosting investment, innovation and job creation in California’s life sciences sector.
CLSA had a chance to speak with STAT News regarding medical research community concerns with AB889, a bill that would threaten the safety of researchers and discovery of new medicines. Check out Rebecca Robbins’ interview with Oliver Rocroi, CLSA’s VP, State Government Relations.
CLSA was recently featured in the news voicing concerns with a newly proposed California law (AB 889) that would add duplicative and burdensome reporting requirements for medical researchers who utilize animal models for testing throughout the Golden State.
CLSA’s hire of Andrew Setikas was recently featured in BioSpace’s Movers & Shakers list.
CLSA was recently featured in BioSpace regarding the Association’s 2018 Life Sciences Champions awards that took place in Sacramento.
CLSA was recently featured in the San Diego Business Journal regarding the expansion of its board.
Assemblyman Rob Bonta, Co-Chair of the California Legislative Rare Disease Caucus, pens an op-ed in The Sacramento Bee on the need to raise awareness and help California develop strong public policies to streamline the drug development pipeline and ensure that everyone with a rare disease gets the treatment they deserve.